“borderline significant”

Also, there was a borderline significant association between the genotype TT/ delTT and PR positive compared to PR negative patients (OR = 3.64, p = 0.055, 95% CI = 0.97–13.59).

Primary bile acid deconjugation potential was lower in IBD patients but only borderline significant after adjustment for FDR (adjusted p value = 0.0551); however, the abundance of the bile salt hydrolase reaction was significantly reduced in IBD microbiomes ( p value 0.0235, Additional file 1 : Table S7) and also differed based on phylum-and genus-level reaction abundances for many taxa (Additional file 1 : Table S7).

Although a chi-square test initially suggested a borderline significant variation across tumor types ( p = 0.0551), this association lost statistical significance after adjusting for multiple comparisons (adjusted p = 0.2057).

For GI bleeds (n=210), two models showed no difference but one model was borderline significant (p<.0552). 4.

When we analyzed the AMD subgroups separately ( Appendix 3 ), we found a borderline significant effect in the Rotterdam Study for the CNV cases (p=0.0554).

Rehabilitation showed a borderline significant effect on 3-month survival ( p = 0.0554), but not on the weaning rate or RCC survival.

For miR-660-5p, a significant (p-value < 0.05) and a borderline significant (p = 0.0554) enrichment of predicted target genes was observed (Fig. 5C ).

In contrast, those with a diagnosis of stage IV disease had a borderline significant association based on their ctDNA KRAS level ( p = 0.0554; Figure 5B ).

Administration of anti-Ly6G antibody significantly suppressed CCRK-induced PMN-MDSC accumulation in liver ( p < 0.01), leading to a borderline significant reduction in HCC tumorigenicity ( p = 0.0555; Supplementary Fig. 5e, f ).

There was also a borderline significant correlation between H19 and G6pc ( P =0.0556; Figure 2h ).

For sulforaphane, the respective decrease was borderline significant (−14.4 ± 21.7%, p = 0.0556).

Age was borderline significant at a 5% level ( p = 0.0556).

A borderline significant interaction was observed for EASI‐90 response rate (37.1% vs. 18.8%, interaction p = 0.0556), indicating a trend toward more pronounced improvement in the comorbid subgroup.

Results suggested that patients in the NADM8 high group tend to be more sensitive to the treatment of PI3K inhibitor GDC-0941 as compared with the NADM8 low group, although it is borderline significant (P = 0.0556) due to the limited sample size ( Figure 6K ).

Among rural dwellers, the non-linearity χ 2 was borderline significant (p=0.0558) thereby indicating possible departure from linearity.

Statistical analysis indicated a borderline significant relationship between tumor morphology and therapy response (Fisher's exact test: p = 5.58 × 10 −2 , n = 67).

6K ), we observed a borderline significant ( P = 0.056) reduction in the EMT signature score in cocultured tumor cells treated with DMXAA ( Fig. 6P ).

This result was borderline significant ( p = 0.056).

This variable entered the broad model as borderline significant ( p = 0.056, 95%-CI = 0.05–1.04), but did not meet the inclusion criteria for the narrow model.

HRs were borderline significant at ≥40% (HR = 1.76, P = .056) and not significant at ≥20% increase at first follow-up; at second follow-up the highest significant HR was found with the ≥20% increase threshold (HR = 10.70, P < .001).

Statistical analysis showed only a borderline significant difference between these two groups of patients ( p = 0.056).

However, there was a borderline significant difference between the two groups ( p = 0.056) in the IDS-C30 score favoring the placebo.

48.3%, p = 0.001, OR 1.93). Initial stroke severity, measured by NIHSS at admission, showed borderline significant differences ( p = 0.056), with patients reporting unspecified symptom duration showing worse severity compared to other groups.

Adjusted for age, this difference was significant for ABCB1 (beta =0.191, p =0.051), and borderline significant for ABCC1 (beta =0.175, p =0.056).

There also is a tendency for women with a drug abuse problem to be more likely to report lifetime screening, but the coefficient was borderline significant ( p = .056).